Vifor Pharma AG (VIFN:SW) (GNHAY) PT Raised to CHF127 at UBS
Tweet
Share
E-mailGet Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Trade Now!
Join SI Premium – FREE
UBS analyst Laura Sutcliffe raised the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF127.00 (from CHF119.00) while maintaining a Neutral rating.
You May Also Be Interested In
- LVMH Moet Hennessy Louis Vuitton SE (MC:FP) (LVMUY) PT Raised to EUR640 at Credit Suisse
- Galaxy Resources Ltd. (GXY:AU) PT Raised to AUD3.80 at Citi
- Outokumpu OYJ (OUT1V:FH) (OUTFF) PT Raised to EUR3.60 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
